Karen Hedine
Micronics, Inc.

Ms. Hedine joined Micronics in 2001 to spearhead business strategy and corporate development efforts; she became President three months later. Under her direction, Micronics has evolved from a research and development company to a globally-recognized, revenue-generating products and services business.  Prior to joining Micronics, Ms Hedine served as General Manager of QIAGEN Genomics, a high throughout SNP genotyping technology and services company.  Prior to that she worked in corporate finance, business development and strategic operational roles for a number of biotech companies including ProCyte Corporation and Genetic Systems (acquired by Bristol, Myers-Squibb). She served as past chair person of the Washington State Biotechnology and Biomedical Association, for which she serves currently as a member of the board, and has consulted on behalf of a number of West Coast biotech and other high tech development-stage companies.  She serves on the diagnostics sector Working Group for the Toronto-based Economic, Social and Cultural  Program for the Grand Challenges in Global Health Initiative. Ms. Hedine is a graduate of the University of Washington with a B.A. in English, and obtained a Masters degree in Personnel Administration from Indiana University.  She is a frequently invited speaker on industry’s role in global health.
< Back to Board of Directors